Ramsay (ASX:RHC) share price falls 6% amid reports of COVID battle plan

COVID-19 has imposed a major challenge on the private hospital operator.

| More on:
Graph showing a fall in share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price is suffering today amid a broader market sell-off.

Meanwhile, reports have emerged that the private hospital operator has its sights set on a hiring spree, bringing in graduate nurses to fight against a COVID-19-exacerbated shortage.

At the time of writing, the Ramsay Health Care share price is $67.58, 5.76% lower than its previous close.

For context, the S&P/ASX 200 Index (ASX: XJO) has slumped 2.78% today, while the All Ordinaries Index (ASX: XAO) is down 2.83%.

Let's take a closer look at Ramsay's apparent plan to staff its hospitals through yet another COVID-19 outbreak.

Ramsay share price slides amid planned hiring spree

According to reporting by The Australian, Ramsay is planning to onboard its highest intake of graduate nurses to battle a shortage of staff made worse by the pandemic.

It expects to employ 550 new graduates – 25% more than it did during 2021.

Previous research by the federal government – conducted in 2014 – forecasts a shortfall of 85,000 nurses by 2025 and 123,000 by 2030.

On top of that, CEO of Ramsay's Australian operations, Carmel Monaghan was quoted as saying that the pandemic has worsened the shortage:

Like all industries, we see the workforce as our most significant challenge for the next few years. Supply has been constrained with borders closed and staff furloughed due to COVID.

Monaghan also stated that some nurses refused to be vaccinated against COVID-19, further exacerbating the shortage.

The Australian noted a shortage of nurses may block the company's hospitals from bouncing back to their full elective surgery capacity.

Elective surgeries are a major income source for Ramsay's private hospitals. In its results for financial year 2021, Ramsay reported that a 90-day restriction on elective surgeries in Victoria had a $70 million impact on the company's earnings before interest and tax.

Similar restrictions were put in place in New South Wales over the first half of financial year 2022 and were one reason behind a 39.5% fall in the company's unaudited net profit after tax for the first quarter of financial year 2022.

Thus, it likely goes without saying that the market will be watching the Ramsay Health Care share price when it releases its results for the first half of financial year 2022.

Monaghan reportedly told The Australian that the company has already received expressions of interest from 500 graduate nurses.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A red heart-shaped balloon floats up above the plain white ones, indicating the best shares.
Healthcare Shares

Heart tech firm's shares surge after huge capital raise

A strategic investor has also jumped on board.

Read more »

Lab technician in lab with a tray of specimens
Healthcare Shares

Has this ASX 200 stock just turned the corner after 7% surge?

Brokers think the volatile biotech share can sustain the rally this time.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »